Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen
Othmar G. Engelhardt(National Institute for Biological Standards and Control), Philip D. Minor(National Institute for Biological Standards and Control), Una Dunleavy(National Institute for Biological Standards and Control), Ruth Harvey(The Francis Crick Institute), Sarah Skeldon(National Institute for Biological Standards and Control), Kate Guilfoyle(National Institute for Biological Standards and Control), Claire Storey(St Mary's Hospital), Rebecca Penn(National Institute for Biological Standards and Control), John Wood(Women's and Children's Hospital), Diane Major(National Institute for Biological Standards and Control), Jun X. Wheeler(National Institute for Biological Standards and Control), Robert W. Newman(National Institute for Biological Standards and Control), Chantal Edge(Department of Health and Social Care)
Cited by 22
Related Papers
Animal models for COVID-19
|Nature|2020|877
Location and primary structure of a major antigenic site for poliovirus neutralization
|Nature|1983|194
Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
|Vaccine|2004|156
Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
|Emerging infectious diseases|2009|150
A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
|Influenza and Other Respiratory Viruses|2007|148